BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD
154 results:

  • 1. TIM3 and CTLA4 immune checkpoint polymorphisms are associated with acute myeloid leukemia in Saudi Arabia.
    Alqahtani M; Aljuaimlani A; Al-Tamimi J; Alomar S; Mansour L
    Hematology; 2024 Dec; 29(1):2329024. PubMed ID: 38536023
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Contrast-enhanced CT-based radiomics differentiate anterior mediastinum lymphoma from thymoma without myasthenia gravis and calcification.
    Huang X; Wang X; Liu Y; Wang Z; Li S; Kuang P
    Clin Radiol; 2024 Apr; 79(4):e500-e510. PubMed ID: 38242804
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial.
    Mori T; Osumi T; Kada A; Ohki K; Koga Y; Fukano R; Fujita N; Mitsui T; Mori T; Saito AM; Nakazawa A; Kobayashi R; Sekimizu M
    Eur J Haematol; 2024 Apr; 112(4):585-593. PubMed ID: 38112205
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Impact of immunosuppression intensified conditioning regimen for patients with strong positive pre-transplantation donor-specific anti-HLA antibodies (DSAs) undergoing haploidentical hematopoietic stem cell transplantation].
    Liu HX; Wei DL; Shao S; Jiang Y; Li S; Zhu J; Wang C; Zhao CX
    Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):654-659. PubMed ID: 37803839
    [No Abstract]    [Full Text] [Related]  

  • 5. Effects of exercise training on cancer patients undergoing neoadjuvant treatment: A systematic review.
    Malveiro C; Correia IR; Cargaleiro C; Magalhães JP; de Matos LV; Hilário S; Sardinha LB; Cardoso MJ
    J Sci Med Sport; 2023 Nov; 26(11):586-592. PubMed ID: 37696693
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia.
    Hoshitsuki K; Zhou Y; Miller AM; Choi JK; Swanson HD; Bhakta NH; Jeha S; Karol SE; Ribeiro RC; Rubnitz JE; Mullighan CG; Cheng C; Yang JJ; Relling MV; Pui CH; Inaba H
    Leukemia; 2023 Sep; 37(9):1782-1791. PubMed ID: 37543655
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemia.
    Johnson PC; Woyach JA; Ulrich A; Marcotte V; Nipp RD; Lage DE; Nelson AM; Newcomb RA; Rice J; Lavoie MW; Ritchie CS; Bartlett N; Stephens DM; Ding W; Owen C; Stone R; Ruppert AS; Mandrekar SJ; Byrd JC; El-Jawahri A; Le-Rademacher J; Rosko A
    J Geriatr Oncol; 2023 Jul; 14(6):101538. PubMed ID: 37329769
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Incidence and Mortality Rates for Childhood Acute Lymphoblastic leukemia in Puerto Rican Hispanics, 2012-2016.
    Montes-Rodríguez IM; Soto-Salgado M; Torres-Cintrón CR; Tomassini-Fernandini JC; Suárez E; Clavell LA; Cadilla CL
    Cancer Epidemiol Biomarkers Prev; 2023 Aug; 32(8):1030-1037. PubMed ID: 37222662
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Inhibitory Effect of Kaempferol on Proliferation of KG1a Cells and Its Mechanism].
    Chen Z; Zhang L; Yuan XF; Gao BH; Zhang B; Wang X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):319-326. PubMed ID: 37096500
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Childhood cancer survival in the highly vulnerable population of South Texas: A cohort study.
    Wu S; Liu Y; Williams M; Aguilar C; Ramirez AG; Mesa R; Tomlinson GE
    PLoS One; 2023; 18(4):e0278354. PubMed ID: 37022991
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Molecular modeling study of pyrrolidine derivatives as novel myeloid cell leukemia-1 inhibitors through combined 3D-QSAR, molecular docking, ADME/Tox and MD simulation techniques.
    Tabti K; Baammi S; Sbai A; Maghat H; Lakhlifi T; Bouachrine M
    J Biomol Struct Dyn; 2023; 41(23):13798-13814. PubMed ID: 36841617
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Rapid LC-MS/MS Bosutinib Quantification with Applications in Metabolic Stability Estimation.
    Attwa MW; Alanazi MM
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838629
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
    Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
    Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Prognostic Value of the Expression of Myeloid leukemia Factor 1-Interacting Protein in Gastric Cancer and Its Regulatory Role in Tumor Progression].
    Yang Z; Zhang H; Xu MY; Zhang XF; Wang YY; Ge ST; Geng ZJ; Song X; Li J; Hu JG; Zuo LG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):114-121. PubMed ID: 36647653
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Gastrointestinal cancer occurs as extramuscular manifestation in FSHD1 patients.
    Kurashige T; Morino H; Ueno H; Murao T; Watanabe T; Hinoi T; Nishino I; Torii T; Maruyama H
    J Hum Genet; 2023 Feb; 68(2):91-95. PubMed ID: 36336708
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Infectious events in pediatric patients with acute lymphoblastic leukemia/lymphoma undergoing evaluation for fever without severe neutropenia.
    Patel PA; DeGroote NP; Jackson K; Cash T; Castellino SM; Jaggi P; Esbenshade AJ; Miller TP
    Cancer; 2022 Dec; 128(23):4129-4138. PubMed ID: 36238979
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion.
    Shen Y; Freeman JA; Holland J; Naidu K; Solterbeck A; Van Bilsen N; Downe P; Kerridge I; Wallman L; Akerman A; Aggarwal A; Milogiannakis V; Martins Costa Gomes G; Doyle CM; Sandgren KJ; Turville S; Cunningham AL; Mulligan SP
    Blood; 2022 Dec; 140(25):2709-2721. PubMed ID: 36206503
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Zandelisib with continuous or intermittent dosing as monotherapy or in combination with rituximab in patients with relapsed or refractory B-cell malignancy: a multicentre, first-in-patient, dose-escalation and dose-expansion, phase 1b trial.
    Pagel JM; Soumerai JD; Reddy N; Jagadeesh D; Stathis A; Asch A; Salman H; Kenkre VP; Iasonos A; Llorin-Sangalang J; Li J; Zelenetz AD
    Lancet Oncol; 2022 Aug; 23(8):1021-1030. PubMed ID: 35835137
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Triptolide inhibits T-cell acute lymphoblastic leukaemia by affecting aberrant epigenetic events in the Wnt signalling pathway.
    Ma Y; Li Y; Huang M; Meng Y
    J Chemother; 2023 May; 35(3):240-249. PubMed ID: 35666085
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Peripherally inserted central catheter-related bloodstream infections in patients with hematological malignancies: A retrospective 7-years single-center study.
    Gao T; Zhu X; Zeng Q; Li X; Luo M; Yu C; Hu L; He J; Li Y; Yang Z; Yang H; Huang X; Gu X; Liu Z
    Am J Infect Control; 2022 Oct; 50(10):1171-1177. PubMed ID: 35108580
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.